CL
HZNP

CSS LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CSS LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,800
Closed -$6.57M – 1022
2023
Q3 		$6.57M Buy
56,800
+39,800
+234% +$4.28M 0.43% 47
2023
Q2 		$1.75M Buy
+17,000
New +$1.79M 0.11% 148
2021
Q1 		– Sell
-7,800
Closed -$571K – 1256
2020
Q4 		$571K Sell
7,800
-32,300
-81% -$2.4M 0.02% 430
2020
Q3 		$3.12M Sell
40,100
-12,100
-23% -$833K 0.15% 138
2020
Q2 		$2.9M Buy
52,200
+18,400
+54% +$787K 0.16% 137
2020
Q1 		$1M Buy
33,800
+21,500
+175% +$727K 0.08% 204
2019
Q4 		$445K Hold
12,300
– – 0.02% 374
2019
Q3 		$335K Buy
12,300
+1,800
+17% +$46.5K 0.02% 365
2019
Q2 		$253K Sell
10,500
-56,400
-84% -$1.43M 0.01% 408
2019
Q1 		$1.77M Buy
66,900
+28,900
+76% +$685K 0.11% 141
2018
Q4 		$742K Hold
38,000
– – 0.05% 240
2018
Q3 		$744K Hold
38,000
– – 0.03% 261
2018
Q2 		$629K Hold
38,000
– – 0.03% 272
2018
Q1 		$540K Sell
38,000
-200
-0.5% -$2.96K 0.03% 300
2017
Q4 		$558K Hold
38,200
– – 0.03% 332
2017
Q3 		$484K Hold
38,200
– – 0.02% 357
2017
Q2 		$453K Buy
38,200
+38,000
+19,000% +$473K 0.02% 368
2017
Q1 		$3K Sell
200
-1,000
-83% -$16.2K ﹤0.01% 626
2016
Q4 		$19K Hold
1,200
– – ﹤0.01% 671
2016
Q3 		$22K Buy
1,200
+200
+20% +$3.91K ﹤0.01% 696
2016
Q2 		$16K Sell
1,000
-30,000
-97% -$485K ﹤0.01% 683
2016
Q1 		$514K Sell
31,000
-31,000
-50% -$542K 0.03% 332
2015
Q4 		$1.34M Buy
62,000
+52,000
+520% +$1.01M 0.08% 204
2015
Q3 		$198K Buy
+10,000
New +$316K 0.01% 588

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CSS LLC's HZNP Position: Q4 2023 in Review

CSS LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 32,276 shares — an estimated $3.73M sold.

CSS LLC first reported a position in HZNP in Q4 2015 and held it in 15 quarters. The position peaked at $8.33M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CSS LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CSS LLC sold 32,276 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.73M.
  • CSS LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 15 quarters.
  • CSS LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.33M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CSS LLC's 13F filing for Q4 2023, filed 14 Feb 2024.